In 1999, the 20-year-old AIDS crisis has ruined many developing countries and, in particular, on the African continent. Of the estimated 33.4 million people living with HIV / AIDS around the world in 1998, almost two-thirds (22 million) were in sub-Saharan Africa, considered the "global epicenter" of the disease. For 12 million people died, and life expectancy in the region has fallen from 62 to 47 years. Chicago-based Abbott Laboratories said early outbreak of AIDS through the development of an HIV test diagnostic kit, and then, later on in the crisis, developed some of the state-of-the-art HIV / AIDS. Abbott executives, led by the new CEO Miles White, wanted to address the crisis in sub-Saharan Africa, but also in concrete, effective and efficient way. This case in detail the evolution of the AIDS crisis, HIV / AIDS Abbott Laboratories' drug production, and the company's efforts in 1999 to find other ways to fight HIV / AIDS around the world.
This Darden study. "Hide
by Pat Werhane, Jenny Mead Source: Darden School of Business 10 pages. Publication Date: February 29, 2008. Prod. #: UV1157-PDF-ENG
Related Case Solutions & Analyses:
Nucor at a Crossroads
Note on Organization Structure
Siemens Electric Motor Works (A): Process-Oriented Costing
Kristens Cookie Co. (A)
TransMilenio: The Battle Over Avenida Septima
Tata Consultancy Services: Selling Certainty
RemicadeSimponi: Confidential Instructions for Johnson & Johnson
The Writing Process in Systems Thinking
ROCKWATER INSURANCE
Adam Opel AG (B)
